Efficacy of Topical Capsaicin Cream for Stable Angina
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Stable Angina
In brief
The purpose of this study is to test the hypothesis that application of topical capsaicin in patients with stable angina will result in improved exercise tolerance and reduced cardiac ischemia.
Key facts
- Study ID
- NCT01231750
- Run by
- Neal Weintraub
- People needed
- 7
- Starts
- 2010-10-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2015-06-25
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- > or = 3 month history of chronic, stable, angina triggered by physical effort or mental/emotional stress
- documented stress-induced ST depression, reversible perfusion imaging, or wall motion abnormality or CAD >50%
- Canadian Cardiovascular (CV) Class I-III
- Receiving medical therapy for > or = 2 months
- Ability to perform Bruce Protocol treadmill test
- non-pregnant female
You may not qualify if…
- unstable angina
- revasc within 2 months
- Myocardial infarction (MI) within 2 months
- congestive heart failure (CHF) hospitalization within 2 months
- New York Heart Association (NYHA) class III or IV
- left ventricular ejection fraction (LVEF) < 25%
- abnormal ECG; Acute changes on ECG
- Currently receiving treatment with investigational drugs/devices
- Uncontrolled hypertension
- contraindication to exercise stress testing
- allergy to red peppers or capsaicin
- skin deformity, scar, or rash at application site
- abdominal surgery within 3 months
Where it is running
- University of Cincinnati Physicians, Inc — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.